Dana Investment Advisors, Inc.

Position in VKTX — Viking Therapeutics, Inc.

CIK 1427514 BROOKFIELD, WI

Position in VKTX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$1,944,460

-$25,373 QoQ

Shares Held

59,756

+6.7% QoQ

Ownership

0.051%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 95.6908092911172.ToString("F0")% Shared 0.ToString("F0")% None 4.30919070888279.ToString("F0")%

Healthcare · as of Mar 31, 2026

Dana Investment Advisors, Inc. holds $35,335,939 across 12 Biotechnology names. VKTX ranks #4 (5.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc	69,234	$13,822,568
2	REGN	Regeneron Pharmaceuticals, Inc.	8,397	$6,487,858
3	AXSM	Axsome Therapeutics, Inc.	26,379	$4,458,578
4	VKTX	Viking Therapeutics, Inc. This page	59,756	$1,944,460
5	MDGL	Madrigal Pharmaceuticals, Inc.	3,197	$1,673,533
6	TGTX	Tg Therapeutics, Inc.	43,954	$1,460,151
7	ZYME	Zymeworks Inc.	56,107	$1,404,919
8	IONS	Ionis Pharmaceuticals Inc	18,487	$1,388,188

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,944,460	59,756	+6.7%	Shares	Sole	2026-05-14
2025-12-31	$1,969,833	55,993	-15.1%	Shares	Sole	2026-02-05
2025-09-30	$1,734,059	65,984	+45.4%	Shares	Sole	2025-11-10
2025-06-30	$1,202,808	45,389	+137.0%	Shares	Sole	2025-08-13
2025-03-31	$462,520	19,152	+14.3%	Shares	Sole	2025-05-15
2024-12-31	$674,060	16,751	-15.7%	Shares	Sole	2025-02-06
2024-09-30	$1,257,336	19,860	+99.7%	Shares	Sole	2024-11-13
2024-06-30	$527,078	9,943	+242.7%	Shares	Sole	2024-08-27
2024-03-31	$237,882	2,901	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.